PONTOCEREBELLAR HYPOPLASIA, TYPE 1C
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Pontocerebellar hypoplasia type 1 for the neuropediatrician: Genotype-phenotype correlations and diagnostic guidelines based on new cases and overview of the literature.
|
29656927 |
2018 |
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C
|
0.710 |
GeneticVariation
|
disease |
BEFREE |
EXOSC8 mutations alter mRNA metabolism and cause hypomyelination with spinal muscular atrophy and cerebellar hypoplasia.
|
24989451 |
2014 |
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
EXOSC8 mutations alter mRNA metabolism and cause hypomyelination with spinal muscular atrophy and cerebellar hypoplasia.
|
24989451 |
2014 |
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
EXOSC8 mutations alter mRNA metabolism and cause hypomyelination with spinal muscular atrophy and cerebellar hypoplasia.
|
24989451 |
2014 |
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C
|
0.710 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C
|
0.710 |
Biomarker
|
disease |
CTD_human |
|
|
|
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C
|
0.710 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Pontocerebellar Hypoplasia Type 1
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
EXOSC8 mutations alter mRNA metabolism and cause hypomyelination with spinal muscular atrophy and cerebellar hypoplasia.
|
24989451 |
2014 |
Spinal Muscular Atrophy
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Other EXOSC3 mutations and EXOSC8 cases are intermediate - SMA type 1-like presentation, spasticity (mostly in EXOSC8) and death between 3 months and 5 years.
|
29656927 |
2018 |
Spinal Muscular Atrophy
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Failure to Thrive
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Muscle Weakness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Feeding difficulties
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hypoplasia of corpus callosum
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Global developmental delay
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Spastic tetraparesis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Respiratory Failure
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
hearing impairment
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cerebellar vermis hypoplasia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Visual Impairment
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cerebral cortical atrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Neurodegenerative Disorders
|
0.020 |
GeneticVariation
|
group |
BEFREE |
In contrast, mutations in the structural exosome genes EXOSC3 and EXOSC8 cause pontocerebellar hypoplasia type 1b (PCH1b) and type 1c (PCH1c), respectively, which are related autosomal recessive, neurodegenerative diseases.
|
31768969 |
2020 |
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B
|
0.020 |
Biomarker
|
disease |
BEFREE |
In contrast, mutations in the structural exosome genes EXOSC3 and EXOSC8 cause pontocerebellar hypoplasia type 1b (PCH1b) and type 1c (PCH1c), respectively, which are related autosomal recessive, neurodegenerative diseases.
|
31768969 |
2020 |
Neurodegenerative Disorders
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Mutations in the RNA exosome genes <i>EXOSC3</i> and <i>EXOSC8</i> cause pontocerebellar hypoplasia type 1b (PCH1b) and type 1c (PCH1c), respectively, which are similar autosomal-recessive, neurodegenerative diseases.
|
29093021 |
2018 |
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the RNA exosome genes <i>EXOSC3</i> and <i>EXOSC8</i> cause pontocerebellar hypoplasia type 1b (PCH1b) and type 1c (PCH1c), respectively, which are similar autosomal-recessive, neurodegenerative diseases.
|
29093021 |
2018 |